Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 32 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 8wl2:A0 (3.4) BS01 peptide N/A N/A P16437 N/A
    2 8wl2:A0 (3.4) BS02 peptide N/A N/A P16437 N/A
    3 8wl2:A5 (3.4) BS01 peptide N/A N/A P26462 N/A
    4 8wl2:A6 (3.4) BS01 peptide N/A N/A P16437 N/A
    5 8wl2:A6 (3.4) BS02 peptide N/A N/A P16437 N/A
    6 8wl2:A7 (3.4) BS01 peptide N/A N/A P16437 N/A
    7 8wl2:A7 (3.4) BS02 peptide N/A N/A P16437 N/A
    8 8wl2:A8 (3.4) BS01 peptide N/A N/A P16437 N/A
    9 8wl2:A8 (3.4) BS02 peptide N/A N/A P16437 N/A
    10 8wl2:A9 (3.4) BS01 peptide N/A N/A P16437 N/A
    11 8wl2:A9 (3.4) BS02 peptide N/A N/A P16437 N/A
    12 8wl2:AA (3.4) BS01 peptide N/A N/A P16323 N/A
    13 8wl2:AA (3.4) BS02 peptide N/A N/A P16323 N/A
    14 8wl2:AB (3.4) BS01 peptide N/A N/A P16323 N/A
    15 8wl2:AB (3.4) BS02 peptide N/A N/A P16323 N/A
    16 8wl2:AC (3.4) BS01 peptide N/A N/A P16323 N/A
    17 8wl2:AC (3.4) BS02 peptide N/A N/A P16323 N/A
    18 8wl2:AD (3.4) BS01 peptide N/A N/A P16323 N/A
    19 8wl2:AD (3.4) BS02 peptide N/A N/A P16323 N/A
    20 8wl2:AE (3.4) BS01 peptide N/A N/A P16323 N/A
    21 8wl2:AE (3.4) BS02 peptide N/A N/A P16323 N/A
    22 8wl2:AI (3.4) BS01 peptide N/A N/A P0A1J3 N/A
    23 8wl2:AV (3.4) BS01 peptide N/A N/A P15928 N/A
    24 8wl2:Ao (3.4) BS01 peptide N/A N/A P15928 N/A
    25 8wl2:BA (3.4) BS01 peptide N/A N/A P0A1I7 N/A
    26 8wl2:BA (3.4) BS02 peptide N/A N/A P0A1I7 N/A
    27 8wl2:BB (3.4) BS01 peptide N/A N/A P0A1I7 N/A
    28 8wl2:BC (3.4) BS01 peptide N/A N/A P0A1I7 N/A
    29 8wl2:BD (3.4) BS01 peptide N/A N/A P0A1I7 N/A
    30 8wl2:BE (3.4) BS01 peptide N/A N/A P0A1I7 N/A
    31 8wl2:BF (3.4) BS01 peptide N/A N/A P0A1I7 N/A
    32 8wl2:BF (3.4) BS02 peptide N/A N/A P0A1I7 N/A
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218